Age-related decrease in the activity of collagenase in the femoral head in patients with hip osteoarthritis

Zgoda, Marcin; Pączek, Leszek; Bartlomiejczyk, I; Siemińska, Jolanta; Chmielewski, Dariusz; Górecki, A

doi:10.1007/s10067-006-0472-2

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Knee OA accounts for over 80% of the diseases total burden and affects at least 19% of the U.S. population aged 45 or older . Risk factors for OA include age, obesity, trauma, genetics, muscle weakness, prior surgery, and repetitive use among others . Age and obesity are consistently correlated with the prevalence of OA, with one epidemiological study reporting that evidence of OA can be found in 44% and 42.6% of males and females over the age of 30, respectively .…”

Section: Introductionmentioning

confidence: 99%

Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis

Mautner

Bowers

Easley

et al. 2019

Stem Cells Translational Medicine

135

View full text Add to dashboard Cite

This study aimed to determine whether autologous orthobiologic tissue source affects pain and functional outcomes in patients with symptomatic knee osteoarthritis (OA) who received microfragmented adipose tissue (MFAT) or bone marrow aspirate concentrate (BMAC) injection. We retrospectively reviewed prospectively collected data from patients who received BMAC or MFAT injection for symptomatic knee OA. Patients completed baseline and follow‐up surveys. Each survey included the Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire, Emory Quality of Life (EQOL) questionnaire, and Visual Analog Scale (VAS) for pain. The follow‐up responses were compared with baseline for all patients and between BMAC and MFAT groups. A total of 110 patients met inclusion criteria, with 76 patients (BMAC 41, MFAT 35) and 106 knees (BMAC 58, MFAT 48) having appropriate follow‐up data. The BMAC group included 17 females and 24 males, with a mean age of 59 ± 11 years. The MFAT group included 23 females and 12 males, with a mean age of 63 ± 11 years. Minimum follow‐up time was 0.5 years. Mean follow‐up time was 1.80 ± 0.88 years for BMAC and 1.09 ± 0.49 years for MFAT. Both groups had significant improvement in EQOL, VAS, and all KOOS parameters preprocedure versus postprocedure (p < .001). There was not a significant difference when comparing postprocedure scores between groups (p = .09, .38, .63, .94, .17, .15, .70, respectively). These data demonstrate significant improvement in pain and function with both MFAT and BMAC injections in patients with symptomatic knee OA without a significant difference in improvement when comparing the two autologous tissue sources. Stem Cells Translational Medicine 2019;8:1149–1156

show abstract

Section: Introductionmentioning

confidence: 99%

Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis

Mautner

Bowers

Easley

et al. 2019

Stem Cells Translational Medicine

135

View full text Add to dashboard Cite

show abstract

Age-related decrease in the activity of collagenase in the femoral head in patients with hip osteoarthritis

Abstract: In the XML version of the online publication the family name of the second author was incorrectly given as Pczek. In fact, the correct family name is Pączek.

Cited by 1 publication

References 7 publications

Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis

Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis

Contact Info

Product

Resources

About